+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Pancreatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Pancreatic Cancer Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 151 Pages
  • Global
From
Colorectal Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Colorectal Cancer Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 363 Pages
  • Global
From
From
From
From
From
Biobanking Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Biobanking Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 140 Pages
  • Global
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Angiopoietin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
From
Genitourinary Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Genitourinary Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 200 Pages
  • Global
From
From
From
Loading Indicator